جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

2 مُخرَج نتائج البحث عن «Kidney»

نسخة أوليةمفتوح (مستودع)2025

Top 50 cited articles on the treatment of chronic kidney disease: a bibliometric analysis

medRxiv

Abstract Introduction As the seventh greatest cause of premature mortality, chronic kidney disease (CKD) affects over 850 million people worldwide and poses a public health concern. Despite extensive research on CKD, it is still unclear which studies have had the greatest impact on treatment practices. Bibliometric analysis provides an evidence-based approach to identify key research trends, priorities, and global disparities. This study aimed to determine the 50 most referenced publications on CKD treatment, examining citation patterns, thematic clusters, evidence quality, and global research distribution. Methods A comprehensive search of the Web of Science Core Collection was performed using the terms “Chronic Kidney Disease” AND “Treatment.” English-language publications involving human CKD treatment were included. After screening in Rayyan, data were extracted on study type, evidence level, treatment modality, and authorship. Analysis proceeded through four steps: (1) data cleaning and standardization; (2) descriptive bibliometrics of publication trends, core journals, and productivity indicators; (3) citation analysis using h-index–type metrics excluding self-citations; and (4) science mapping via VOSviewer and Bibliometrix to visualize keyword co-occurrence networks. Descriptive statistics summarized study characteristics. Results Randomized controlled trials accounted for only 16% of the top 50 papers (2000–2022), while narrative reviews comprised 42% and review articles 16%. Key subjects included SGLT2 inhibitors, metabolic therapies, and renin-angiotensin-aldosterone system blockade. Research output was concentrated in high-income regions, with limited contribution from low- and middle-income countries. Only 24% of publications achieved Level 1 evidence. Conclusion The literature on CKD treatment is geographically imbalanced, centralized, and dominated by narrative evidence. Region-specific bibliometric evaluations and more rigorous multicenter trials are required. For Saudi Arabia, aligning locally generated data with international knowledge is essential to develop equitable, context-driven, and evidence-based CKD management strategies.

chronic kidney diseaseCKD treatmentcitation analysisresearch trends
نسخة أوليةمفتوح (مستودع)2025

Therapeutic potential of mesenchymal stem cells-derived exosomes loaded with elemental or nano selenium on diabetic nephropathy

Research Square

Abstract Endocrinologists and nephrologists continually seek new therapeutic approaches for diabetic nephropathy (DN). Lately, mesenchymal stem cells (MSCs)-derived exosomes (MSCs-EXs) have been applied as natural carriers for targeted drug delivery. Thus, we aim to estimate the therapeutic potentialities of MSCs-EXs loaded with ordinary selenium (Se) or its nanoform (NSe) as a promising cell-free therapy in diabetic nephropathy (DN). Eighty rats were randomly split into 8 groups; control, EXs, EXs + Se, EXs + NSe, diabetic (D), D + EXs, D + EXs + Se, and D + EXs + NSe groups. After 4 weeks, our results indicated renal hypolipidemic and renal ameliorating effects of unloaded or loaded EXs with Se or NSe, evidenced by the declined serum levels of urea, uric acid, and creatinine, compared to diabetic-untreated rats. Such observations might be a reflection of the observed antioxidant activity of both EXs alone or in the combined form with either Se or NSe, evidenced by decreased renal MDA, NO, H2O2 levels coupled with increased GSH, SOD, CAT, and GPX, besides their anti-inflammatory and antiapoptotic effects, indicated by the decreased renal levels of IL-6, TGF-β, TNF-α, BAX, caspase-3, and P53, with Bcl-2 upregulation. Consequently, the kidney architecture in the three diabetic-treated groups was greatly improved. Likely, the EXs-loaded NSe treatment protocol highlighted the DN improvement superiority most significantly compared to the other protocols.

diabetic nephropathymesenchymal stem cell-derived exosomesselenium nanoparticlesselenium